These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4807613)

  • 1. [Investigation and treatment of hemophilia A with inhibitor of factor VIII (author's transl)].
    Fukutake K; Fujimari M; Ukita M; Kitahara T
    Rinsho Ketsueki; 1973 Dec; 14(0):1393-99. PubMed ID: 4807613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitors (antibodies) directed against factor VIII in hemophilia A (author's transl)].
    Beck EA
    Ther Umsch; 1979 Apr; 36(4):326-9. PubMed ID: 377556
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor VIII inhibitors, natural history and management.
    Allain JP
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):241-2. PubMed ID: 524148
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factor VIII inhibitor in a patient with mild haemophilia A (author's transl)].
    Gastaldi G; Avanzi G; Saccon C; Galletti A
    Haematologica; 1975 Dec; 60(4):477-84. PubMed ID: 816717
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevalence of inhibitors in hemophiliacs with reference to the transfusion of blood products (author's transl)].
    Kamiya T
    Rinsho Byori; 1978; 26(4):291-7. PubMed ID: 671775
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incidence of the appearance of factor VIII inhibitor in patients with hemophilia A at the Hemophilia Center of the Clinical Hospital Center in Zagreb].
    Ficović P; Tiefenbach A; Brkljacić V; Grgić Z
    Lijec Vjesn; 1983 Oct; 105(10):410-1. PubMed ID: 6418997
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibitors against factor VIII in hemophilia. A review of treatment possibilities and personal results].
    Scheibel E; Feddersen C
    Ugeskr Laeger; 1985 Nov; 147(47):3803-7. PubMed ID: 3934824
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the human factor VIII (anti-hemophilic factor). II. Properties of human and rabbit antibodies against human factor VIII (author's transl)].
    Niiya K
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):543-52. PubMed ID: 567921
    [No Abstract]   [Full Text] [Related]  

  • 9. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
    Yee TT; Lee CA
    Thromb Haemost; 1999 May; 81(5):852. PubMed ID: 10365768
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of anti-human and anti-porcine factor VIII antibody titers in patients with hemophilia].
    Windyga J; Rzymkiewicz L; Lopaciuk S
    Acta Haematol Pol; 1996; 27(1):27-31. PubMed ID: 8629440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On acquired hemophilia A. A survey of 11 cases.
    Nilsson IM; Lamme S
    Acta Med Scand; 1980; 208(1-2):5-12. PubMed ID: 6159777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Ferencz T; Skopál J; Csáki C; Laczkó M; Schuler D; Borsi J
    Orv Hetil; 1993 Dec; 134(52):2873-5. PubMed ID: 8272354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic antibodies against factor VIII in hemophilia A.
    Stollar BD
    N Engl J Med; 2002 Feb; 346(9):702-3. PubMed ID: 11870249
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of severe bleeding in hemophilia A with factor VIII inhibitor.
    Mahasandana C; Suvatte V; Tanphaichitr VS; Bejrachandra S; Chandanayingyong D
    J Med Assoc Thai; 1988 Mar; 71(3):154-8. PubMed ID: 3133440
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A.
    Delignat S; Dasgupta S; André S; Navarrete AM; Kaveri SV; Bayry J; André MH; Chtourou S; Tellier Z; Lacroix-Desmazes S
    Haematologica; 2007 Oct; 92(10):1423-6. PubMed ID: 18024377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of chronic hepatitis C virus infection by immunoadsorption in factor VIII inhibitor haemophilia.
    Rommel F; Toepfer M; Eberle J; Schiffl H; Spannagl M; Schramm W
    Thromb Haemost; 2000 Oct; 84(4):733-4. PubMed ID: 11057884
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-DR and Factor VIII antibodies in hemophilia A.
    Mayr WR; Lechner K; Niessner H; Pabinger-Fasching I
    Thromb Haemost; 1984 Apr; 51(2):293. PubMed ID: 6429887
    [No Abstract]   [Full Text] [Related]  

  • 20. [Enzyme immunoassay of factor VIII-related antigen with observation in patients with von Willebrand's disease and hemophilia A (author's transl)].
    Okuda T; Masuyama H; Tanigawa T; Narihiro N; Fujimura Y; Takase T; Mikami S; Yoshioka A; Fukui H
    Rinsho Ketsueki; 1980 Jul; 21(7):946-52. PubMed ID: 6775115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.